EchoSeed Model 6733 Iodine‐125 brachytherapy source: Improved dosimetric characterization using the MCNP5 Monte Carlo code
- 16 July 2012
- journal article
- Published by Wiley in Medical Physics
- Vol. 39 (8) , 4653-4659
Abstract
This study primarily aimed to obtain the dosimetric characteristics of the Model 6733 125I seed (EchoSeed) with improved precision and accuracy using a more up‐to‐date Monte‐Carlo code and data (MCNP5) compared to previously published results, including an uncertainty analysis. Its secondary aim was to compare the results obtained using the MCNP5, MCNP4c2, and PTRAN codes for simulation of this low‐energy photon‐emitting source. The EchoSeed geometry and chemical compositions together with a published 125I spectrum were used to perform dosimetric characterization of this source as per the updated AAPM TG‐43 protocol. These simulations were performed in liquid water material in order to obtain the clinically applicable dosimetric parameters for this source model. Dose rate constants in liquid water, derived from MCNP4c2 and MCNP5 simulations, were found to be 0.993 cGyh−1 U−1 (±1.73%) and 0.965 cGyh−1 U−1 (±1.68%), respectively. Overall, the MCNP5 derived radial dose and 2D anisotropy functions results were generally closer to the measured data (within ±4%) than MCNP4c and the published data for PTRAN code (Version 7.43), while the opposite was seen for dose rate constant. The generally improved MCNP5 Monte Carlo simulation may be attributed to a more recent and accurate cross‐section library. However, some of the data points in the results obtained from the above‐mentioned Monte Carlo codes showed no statistically significant differences. Derived dosimetric characteristics in liquid water are provided for clinical applications of this source model.Keywords
This publication has 25 references indexed in Scilit:
- Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the 125I I-Seed AgX100 source modelBrachytherapy, 2012
- Dose calculation for permanent prostate implants incorporating spatially anisotropic linearly time‐resolving edemaMedical Physics, 2011
- Modified COMS Plaques for 125I and 103Pd Iris Melanoma BrachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implantMedical Physics, 2009
- Monte Carlo radiation dose simulations and dosimetric comparison of the model 6711 and 9011 brachytherapy sourcesMedical Physics, 2009
- Supplement to the 2004 update of the AAPM Task Group No. 43 ReportMedical Physics, 2007
- Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- 12-YEAR OUTCOMES FOLLOWING PERMANENT PROSTATE BRACHYTHERAPY IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 2005
- Improved radial dose function estimation using current version MCNP Monte-Carlo simulation: Model 6711 and ISC3500 125I brachytherapy sourcesApplied Radiation and Isotopes, 2004
- A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed™ Model 6733 125I brachytherapy sourceBrachytherapy, 2002